OSL oncosil medical ltd

SRX failed Overall Progression free survival which measures...

  1. 16,868 Posts.
    lightbulb Created with Sketch. 836
    SRX failed Overall Progression free survival which measures progression of existing tumours and/or the development of new tumours in any organ or body site . Oncosil showing stable disease which is progression free survival.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.16
Change
-0.070(5.69%)
Mkt cap ! $16.49M
Open High Low Value Volume
$1.25 $1.25 $1.11 $72.36K 60.96K

Buyers (Bids)

No. Vol. Price($)
1 9286 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.18 412 1
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
OSL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.